TEVA

Teva Pharmaceutical Industries Limited

9.85 USD
+0.05 (+0.51%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Teva Pharmaceutical Industries Limited stock is up 15.2% since 30 days ago. The next earnings date is Feb 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 64.71% of the previous 33 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 2 CALLs, 8 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
27 Nov 15:10 19 Jan, 2024 5.00 CALL 80 1774
27 Nov 16:23 17 Jan, 2025 12.00 PUT 140 2262
27 Nov 16:44 17 Jan, 2025 12.00 PUT 100 2262
27 Nov 16:46 19 Jan, 2024 10.00 PUT 500 17500
27 Nov 16:46 17 Jan, 2025 12.00 PUT 100 2262
27 Nov 17:09 17 Jan, 2025 12.00 PUT 100 2262
27 Nov 17:10 17 Jan, 2025 12.00 PUT 100 2262
27 Nov 17:11 17 Jan, 2025 12.00 PUT 100 2262
27 Nov 17:13 17 Jan, 2025 12.00 PUT 100 2262
28 Nov 15:14 17 Jan, 2025 7.00 CALL 430 2844

About Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited sells generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. Its products in the central nervous system, pain, respiratory, and oncology areas include Copaxone for the treatment of relapsing forms of multiple sclerosis. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.